Published in Ann Intern Med on May 01, 1974
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. J Clin Invest (1978) 2.72
Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia. J Clin Microbiol (1993) 2.49
Detection of Aspergillus antigens associated with invasive infection. J Clin Microbiol (1990) 1.83
Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol (1986) 1.82
Detection of yeasts and filamentous fungi in blood cultures during a 10-year period (1972 to 1981). J Clin Microbiol (1982) 1.52
Detection of galactomannan antigenemia by enzyme immunoassay in experimental invasive aspergillosis. J Clin Microbiol (1987) 1.44
Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice. Infect Immun (1980) 1.34
Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice. Infect Immun (1978) 1.31
Detection of fungemia obscured by concomitant bacteremia: in vitro and in vivo studies. J Clin Microbiol (1982) 1.28
Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice. Infect Immun (1982) 1.23
Candida and "20th-century disease". CMAJ (1985) 1.15
Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B. Ann Surg (1982) 1.09
In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon. Infect Immun (1989) 1.07
Diagnosis of systemic or visceral candidosis. Can Med Assoc J (1982) 1.01
Rhodotorula glutinis-related meningitis. J Clin Microbiol (2001) 1.00
Disseminated candidiasis caused by a sucrose-negative variant of Candida tropicalis. J Clin Microbiol (1984) 0.86
Chemotherapy of experimental endogenous Candida albicans endophthalmitis. Trans Am Ophthalmol Soc (1980) 0.84
Syringomyelia associated with post-meningitic spinal arachnoiditis due to Candida tropicalis. Postgrad Med J (1991) 0.77
Experimental hematogenous Candida endophthalmitis: diagnostic approaches. Infect Immun (1979) 0.75
Bilateral endogenous fungal endophthalmitis. Int Ophthalmol (2013) 0.75
Infectious diseases: fortieth and final annual review of significant publications. Postgrad Med J (1975) 0.75
A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry (1978) 25.54
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis (2001) 12.73
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med (1994) 9.11
Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol (1982) 6.78
Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med (1974) 6.75
Cornell Scale for Depression in Dementia. Biol Psychiatry (1988) 6.61
'Vascular depression' hypothesis. Arch Gen Psychiatry (1997) 6.59
Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine. Antimicrob Agents Chemother (1973) 5.84
Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol (1984) 5.74
A pharmacologic guide to the clinical use of amphotericin B. J Infect Dis (1969) 5.58
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol (1989) 5.44
Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. J Clin Microbiol (1986) 5.19
Recruitment of p300/CBP in p53-dependent signal pathways. Cell (1997) 5.10
Serologic grouping of Cryptococcus neoformans. Proc Soc Exp Biol Med (1968) 4.97
Taxonomic studies on Filobasidiella species and their anamorphs. Antonie Van Leeuwenhoek (1982) 4.90
Qualitative and quantitative studies of AKR-type murine leukemia virus sequences in mouse DNA. Cold Spring Harb Symp Quant Biol (1975) 4.49
Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. J Infect Dis (1983) 4.42
Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med (1971) 4.41
Chemotherapy of systemic mycoses (first of two parts). N Engl J Med (1974) 4.20
The Saccharomyces cerevisiae RAD30 gene, a homologue of Escherichia coli dinB and umuC, is DNA damage inducible and functions in a novel error-free postreplication repair mechanism. Genetics (1997) 4.04
Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol (1977) 3.91
Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States. Antimicrob Agents Chemother (1982) 3.91
Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med (1996) 3.76
Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J Infect Dis (1972) 3.75
Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis (2000) 3.70
Distribution of alpha and alpha mating types of Cryptococcus neoformans among natural and clinical isolates. Am J Epidemiol (1978) 3.55
Control for rheumatoid factor in the latex test for cryptococcosis. Am J Clin Pathol (1971) 3.47
The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J Immunol (1974) 3.38
Sepsis with a new species of Corynebacterium. Ann Intern Med (1976) 3.23
Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science (1977) 3.11
Capsular polysaccharides of Cryptococcus neoformans. Rev Infect Dis (1984) 3.10
Evidence that the AKR murine-leukemia-virus genome is complete in DNA of the high-virus AKR mouse and incomplete in the DNA of the "virus-negative" NIH mouse. Proc Natl Acad Sci U S A (1974) 2.95
AKR murine leukemia virus genome: frequency of sequences in DNA of high-, low-, and non-virus-yielding mouse strains. Proc Natl Acad Sci U S A (1974) 2.91
Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res (1983) 2.90
Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin Hematol (1974) 2.89
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. V. Isolation of additional hybrids which differ in their simian virus 40-specific biological properties. J Virol (1973) 2.87
Amphotericin B pharmacokinetics in humans. Antimicrob Agents Chemother (1978) 2.79
Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res (1987) 2.67
Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol (1973) 2.61
Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans. J Infect Dis (1973) 2.45
Growth of Cryptococcus neoformans within human macrophages in vitro. Infect Immun (1973) 2.39
Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med (1978) 2.36
Bacteriological Examination of Glassware or China for Sanitary Quality. Am J Public Health Nations Health (1936) 2.35
Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob Agents Chemother (1995) 2.32
Reversal of adriamycin resistance by verapamil in human ovarian cancer. Science (1984) 2.24
Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene (1994) 2.21
Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med (1977) 2.20
Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients and experimentally infected rabbits. J Infect Dis (1987) 2.18
A study of the relationship of reticuloendotheliosis virus to the avian leukosis-sarcoma complex of viruses. Virology (1973) 2.16
Pharmacological studies with 5-fluorocytosine. Antimicrob Agents Chemother (1972) 2.14
Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique. J Clin Microbiol (1979) 2.13
Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis (1995) 2.11
Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect Immun (1991) 2.11
Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med (1980) 2.07
Clinically defined vascular depression. Am J Psychiatry (1997) 2.06
New, special stain for histopathological diagnosis of cryptococcosis. J Clin Microbiol (1981) 2.04
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. VII. Characterization of the simian virus 40 RNA species induced by five nondefective hybrid viruses. J Virol (1973) 2.02
Staging laparotomy in early ovarian cancer. JAMA (1983) 2.02
The anthracycline antineoplastic drugs. N Engl J Med (1981) 2.02
TB testing. Vet Rec (1996) 2.01
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. VI. Characterization of the DNA from five nondefective hybrid viruses. J Virol (1973) 2.01
Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med (1997) 2.01
5-fluorocytosine resistance in Cryptococcus neoformans. Antimicrob Agents Chemother (1973) 2.00
Clotrimazole: new drug for systemic mycoses? Ann Intern Med (1970) 1.99
Toxic effects of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep (1980) 1.99
Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection. J Allergy Clin Immunol (1975) 1.99
Virus-specific nucleic acids in SV40-exposed hamster embryo cell lines: correlation with S and T antigens. Proc Natl Acad Sci U S A (1969) 1.97
Invasive aspergillosis. Absence of detectable antibody response. Am Rev Respir Dis (1971) 1.96
The epidemic of acquired immune dysfunction in homosexual men and its sequelae--opportunistic infections, Kaposi's sarcoma, and other malignancies: an update and interpretation. Cancer Treat Rep (1982) 1.96
Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol (2006) 1.94
The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiatry (1993) 1.92
Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem Pharmacol (1985) 1.86
Regulation of SOS mutagenesis by proteolysis. Proc Natl Acad Sci U S A (1996) 1.84
Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol (1998) 1.83
Biochemical differences between serotypes of Cryptococcus neoformans. Sabouraudia (1978) 1.83
Complement depletion in cryptococcal sepsis. J Immunol (1978) 1.82
Use of a Pseudomonas Aeruginosa vaccine in pateints with acute leukemia and cystic fibrosis. Am J Med (1975) 1.81
Stable binding of human XPC complex to irradiated DNA confers strong discrimination for damaged sites. J Mol Biol (2000) 1.79
Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry (2000) 1.78
Management of infections in patients with leukemia and lymphoma: current concepts and experimental approaches. Semin Hematol (1972) 1.78
Serology of human cryptococcosis. Ann Intern Med (1968) 1.78
Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature (1973) 1.78
A 127 kDa component of a UV-damaged DNA-binding complex, which is defective in some xeroderma pigmentosum group E patients, is homologous to a slime mold protein. Nucleic Acids Res (1993) 1.76
Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob Agents Chemother (1998) 1.76
Synthesis and processing of the precursor to the major core protein of adenovirus type 2. J Virol (1977) 1.76
Structure of two adenovirus-simian virus 40 hybrids which contain the entire SV40 genome. J Mol Biol (1974) 1.76
Chemotherapy of ovarian cancer. Semin Oncol (1984) 1.75
A rapid method for cloning mutagenic DNA repair genes: isolation of umu-complementing genes from multidrug resistance plasmids R391, R446b, and R471a. J Bacteriol (1993) 1.75
Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides (1985) 1.75
The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300. EMBO J (1996) 1.75
Targeting of the UmuD, UmuD', and MucA' mutagenesis proteins to DNA by RecA protein. Proc Natl Acad Sci U S A (1993) 1.75
Avian reticuloendotheliosis virus (strain T): V. DNA polymerase. Virology (1972) 1.75
Localization of the immune response in sarcoidosis. Am Rev Respir Dis (1979) 1.74